Results

Total Results: 722 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

301. Stakeholder Involvement in Improving Comparative Effectiveness Reviews: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
     September 01, 2011 - or treatment. … ; • Whether the new treatment is less invasive than existing treatments; • Patient preferences; • … Particle beam therapy (PBT) is a focused radiation therapy used to treat certain arteriovenous malformations … “Treating Type 2 Diabetes, The Oral Diabetes Drugs, comparing Effectiveness, Safety, and Price.” … Particle Beam Radiation Therapies for Cancer.

302. Grades-Predictive-Values White-Paper-2015 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
     January 01, 2015 - Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone … Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. … Spinal manipulative therapy for chronic low-back pain. … Insulin detemir versus insulin glargine for type 2 diabetes mellitus. … Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis

303. Cer-250-Cannabis-2024-Surv-Rep-Update-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
     January 01, 2024 - Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % N Interventions Dose Treatment … Long NR Ischemic heart disease, hypertension, heart failure, chronic obstructive pulmonary disease, diabetes … agent, cancer as underlying pain diagnosis, and history of cardiometabolic disease (e.g., hypertension, diabetes … B: Dronabinol as an add-on treatment Mean (SD) A: 16.6 (6.5) mg THC/15.4 (4.1) mg CBD/day B: 17.2 (7.6 … B: Long-acting opioid analgesics as an add-on treatment Mean (SD) A: 6.2 (2.4) sprays/day (16.74 mg

304. Strategies for Patient, Family and Caregiver Engagement: Technical Brief Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-family-engagement-protocol.pdf
     December 31, 2019 - self-management o Self-management programs o Shared decision making (e.g., palliative or end of life or treatment … Diabetes Res Clin Pract. 2013 May;100(2):145-61. doi: 10.1016/j.diabres.2012.12.016. … National standards for diabetes self-management education. … Diabetes Care. 2012 Jan;35 Suppl 1:S101-8. doi: 10.2337/dc12-s101. PMID: 22187467. 8. … Managing depression as a chronic disease: a randomised trial of ongoing treatment in primary care.

305. Kidney-Stone-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
     March 01, 2013 - stones also may be increased by medical conditions such as primary hyperparathyroidism,18 obesity,19 diabetes … with placebo, usual care/no treatment, or other available active treatments. … when added to this diet therapy. … important clinical subgroups included (e.g., gender, single vs. multiple past stone episodes, obesity, diabetes … Diabetes mellitus and the risk of nephrolithiasis. Kidney International. 2005 Sep;68(3):1230-5.

306. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research

307. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - JIA is an important cause of chronic disease in childhood, with prevalence similar to type I diabetes … There is no cure for JIA, but over the past 25 years new therapies have provided great advances in treatment … includes multiple categories, which could potentially respond differentially to therapy. … definitions for, and systematic ascertainment and reporting of, adverse events possibly associated with therapeutic … our ability to detect promising new treatments.

308. Glaucoma-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
     April 01, 2012 - Medical Treatment of Open-Angle Glaucoma KQ1a: Comparative Effectiveness of Medical Treatments for … Reducing Visual Impairment • No studies of medical therapy were identified that directly addressed … Circadian Intraocular Pressure • Our conclusions regarding the effect of topical therapies in lowering … Given the slowly progressive nature of glaucoma, the large trials of glaucoma therapy have demonstrated … any significant conclusions about the comparative effectiveness of most currently used therapies.

309. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
     March 01, 2009 - Clinical conditions were defined as having both diagnosis for a condition and treatment indicating … These comorbidities include arrhythmias, diabetes, cerebrovascular disease (e.g., both cerebral hemorrhagic … Report Number 11 6 Discussion In this study of over 30,000 elderly patients initiating APM treatments … Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? … therapy 1.11 (0.89-1.38) 1.06 (0.79-1.41) 80-180 days after beginning therapy 1.20 (1.03-1.41) 1.25

310. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
     September 13, 2012 - agents as opposed to drawing distinctions between individual therapeutic agents. … Comparisons will be made both within and across classes of therapies. … Antibiotic treatments for chronic venous ulcers Class Indications Drug names Benefits Disadvantages … Surgical treatments for chronic venous ulcers Pathology Treatment Superficial veins reflux Vein stripping … managing chronic wounds, including the application of case definitions for infection and initiating therapies

311. Renal-Function Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
     June 13, 2013 - characteristic ST elevation myocardial infarction (STEMI) can be evaluated for emergent reperfusion therapy … For example, therapy for type II MIs is most often directed at treating the underlying medical condition … Comorbidities (e.g., diabetes, hypertension) i. … Comorbidities (e.g., diabetes, hypertension) i. … Comorbidities (e.g., diabetes, hypertension) i.

312. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
     February 23, 2012 - interdisciplinary process to raise the likelihood of the delivery of best practices for preventive, diagnostic, therapeutic … Individuals in the United States with a priority condition (i.e. breast cancer, colorectal cancer, diabetes … Unequal treatment : confronting racial and ethnic disparities in health care. … Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. … Footnote one states: Priority conditions include: colorectal cancer screening; diabetes; congestive

313. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
     August 22, 2008 - these measures show that patients with CF are at a disadvantage in terms of height and weight, and treatments … Adverse effects of interest include, but are not limited to: glucose intolerance, diabetes, and hypoglycemia … duration, baseline nutritional status, and concurrent medical therapies? … associated with rhGH use are also evaluated, including altered glucose metabolism, development of diabetes … (sex, age, ethnicity, nutritional status), co-morbidities, and use of concurrent standard medical therapies

314. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
     November 27, 2012 - We agree but have included information based on information regarding recommended or considered therapies … mortality when their disease is not treated and it impacts co-morbid health conditions (hypertension, diabetes … unpredictable onset and severity of symptoms, daytime occurrence, and symptoms occurring outside the therapeutic … Polysomnography Data We feel sleep data would make a valuable contribution to the characterization of the therapeutic … effects of RLS treatments for Key Question 1.

315. Defining an Optimal Format for Presenting Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
     January 01, 2019 - pseudorandom numbers to select 50 systematic reviews that included at least one meta-analysis of therapeutic … The probabilities of all 14 treatments at each willingness-to-pay threshold sum to 1. … in type 2 diabetes: systematic review and meta-analysis 2007 JAMA 19509383 Corticosteroids in the … Ann Intern Med 17237299 Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes … Ann Intern Med 19620144 Systematic review: glucose control and cardiovascular disease in type 2 diabetes

316. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting-future_research.pdf
     January 01, 2014 - 4 3.78 7 What is the impact on clinical outcomes of a treatment decision (medical therapy, stent … 3 3.67 8 What is the impact on clinical outcomes of a treatment decision (medical therapy, stent … What is the impact on clinical outcomes of a treatment decision (medical therapy, stent, or bypass) … 4 4.00 7 What is the impact on clinical outcomes of a treatment decision (medical therapy, stent … 3 3.67 8 What is the impact on clinical outcomes of a treatment decision (medical therapy, stent

317. Cer-250-Cannabis-2025-Surv-Rep-Update-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-table-e5.xlsx
     January 01, 2025 - Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % N Interventions Dose Treatment … B Median reported change in NRS scores across treatment sessions: -3.0 (IQR -4.5 to -2.0) NR NR NR NR … Long NR Ischemic heart disease, hypertension, heart failure, chronic obstructive pulmonary disease, diabetes … agent, cancer as underlying pain diagnosis, and history of cardiometabolic disease (e.g., hypertension, diabetes … B: Long-acting opioid analgesics as an add-on treatment Mean (SD) A: 6.2 (2.4) sprays/day (16.74 mg

318. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - In particular how does weight gain or bmi relate to metabolic syndrome and risk for diabetes. … was limited data on many outcomes, but we were able to make some conclusions for some (incidence of diabetes … (e.g., tardive dyskinesias, diabetes). … The other two arms should be described as cognitive therapy + risperidone (n=43) and cognitive therapy … Throughout the report we only describe the arms that were included for this review; the supportive therapy

319. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - In particular how does weight gain or bmi relate to metabolic syndrome and risk for diabetes. … was limited data on many outcomes, but we were able to make some conclusions for some (incidence of diabetes … (e.g., tardive dyskinesias, diabetes). … The other two arms should be described as cognitive therapy + risperidone (n=43) and cognitive therapy … Throughout the report we only describe the arms that were included for this review; the supportive therapy

320. Politi (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
     May 29, 2025 - Sensitive Decisions: • BCS vs. mastectomy for average risk patients with early stage breast cancer • Diabetes … Conversational Recommendations (3) • Discuss how to determine whether there is any benefit  from treatment